CZO Ceapro Inc

Ceapro Inc. (TSX VENTURE:CZO) wishes to inform its shareholders that it has
terminated its month to month contract with Renmark Financial Communications
Inc. to provide investor relations services.


Questions regarding press releases can be forwarded to Branko Jankovic, the
Chief Financial Officer.


About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business
activities relate to the development and commercialization of active ingredients
for personal care and cosmetic industries using proprietary technology and
natural, renewable resources. The commercial line of natural active ingredients
include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat
oil, oat peptides, and lupin peptides.


To learn more about Ceapro, visit www.ceapro.com.

Grafico Azioni Ceapro (TSXV:CZO)
Storico
Da Feb 2025 a Mar 2025

Grafico Azioni Ceapro (TSXV:CZO)
Storico
Da Mar 2024 a Mar 2025